23: Cost-Effectiveness of Sabr in Oligometastatic Cancer: An Economic Analysis Based on Long-Term Results of the SABR-Comet Randomized Trial
Titel:
23: Cost-Effectiveness of Sabr in Oligometastatic Cancer: An Economic Analysis Based on Long-Term Results of the SABR-Comet Randomized Trial
Auteur:
Qu, Melody Chen, Yujie Zaric, Gregory Senan, Suresh Olson, Robert Harrow, Stephen John-Baptiste, Ava Gaede, Stewart Mulroy, Liam Schellenberg, Devin Senthi, Sashendra Swaminath, Anand Kopek, Neil Liu, Mitchell Warner, Andrew Rodrigues, George Palma, David Louie, Alexander